Align Technology (LTS:0HCK) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0HCK Align Technology Inc LTS:0HCK
91 GF Score
Price $181.68
GF Value $241.67
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Align Technology Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

LTS:0HCK
91GF Score
Align Technology Inc LTS:0HCK
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Align Technology (LTS:0HCK) Overvalued in 2026?

Based on GuruFocus' analysis, Align Technology stock appears to be undervalued. The current stock price of $181.68 is trading 24.8% below its estimated GF Value™ of $241.67. GuruFocus considers Align Technology to be Modestly Undervalued.

Key valuation signals for LTS:0HCK:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: $241.67 vs. price of $181.68 (24.8% below fair value)
  • GF Score™: 91/100 with 3 warning signs

No single metric tells the full story. See the LTS:0HCK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Align Technology Business Description

Address 410 North Scottsdale Road, Suite 1300, Tempe, AZ, USA, 85288
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
91GF Score

Get the complete analysis for LTS:0HCK

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$181.68
Price
$241.67
GF Value